Pain Therapeutics, Inc. (PTIE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pain Therapeutics, Inc. (PTIE)

PTIE 12.08

-1.3%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Jack@SI	8/2/2006 11:01:22 AM
	of 28

Another pain drug from the PTIE/King alliance. SOUTH SAN FRANCISCO, Calif. and BRISTOL, Tenn., Aug. 2 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. (Nasdaq: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) announced today the initiation of a Phase I clinical trial to evaluate the effects of PTI-202 in humans. PTI-202 is a new drug candidate in the companies' collaboration to develop abuse-resistant opioid painkillers, a new category of drugs intended to prevent prescription drug abuse. In November 2005, Pain Therapeutics and King Pharmaceuticals announced a broad strategic alliance to develop and commercialize four proprietary lead drug candidates. All four drug candidates are intended to be long-acting, abuse-resistant opioid painkillers. Two of these drug candidates are now in clinical testing: Drug Name Description Clinical Status Remoxy(TM) Abuse-resistant oxycodone Phase III PTI-202 Abuse-resistant opioid (undisclosed) Phase I PTI-202 is a long-acting opioid painkiller. Pain Therapeutics and King Pharmaceuticals have not yet disclosed the active pharmaceutical drug in PTI-202. Pain Therapeutics recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for PTI-202. FDA acceptance of this IND triggered the payment of a $5 million cash milestone from King Pharmaceuticals to Pain Therapeutics. (snip)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next